Amerisure Insurance Company – Trademark Portfolio

Entity Type: 03

Amerisure Insurance Company holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 11 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include AMERISURE COMMAND COVERAGE, MANUFACTURERS ADVANTAGE PROGRAM, and AMERISURE CONTRACTORS ADVANTAGE PROGRAM. The owner is based in Farmington Hills, MI.

26777 Halsted Road

Farmington Hills, MI 483313586

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Amerisure Insurance Company's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (11 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Amerisure Insurance Company have?

Amerisure Insurance Company has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned, 3 cancelled.

What trademark classes does Amerisure Insurance Company file in?

Amerisure Insurance Company files trademarks across 1 Nice Classification class. The most active classes are Class 36 (Insurance & Financial). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Amerisure Insurance Company's most well-known trademarks?

Amerisure Insurance Company's registered trademark portfolio includes well-known marks such as AMERISURE COMMAND COVERAGE, MANUFACTURERS ADVANTAGE PROGRAM, and AMERISURE CONTRACTORS ADVANTAGE PROGRAM. These are among 3 currently registered trademarks in the portfolio.

What is Amerisure Insurance Company's trademark registration success rate?

Amerisure Insurance Company has a 27% trademark registration rate, with 3 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.